Role of NINJ1 in Gout Flare and Potential as a Drug Target
DOI: https://doi.org/10.2147/JIR.S378341
IF: 4.5
2022-09-29
Journal of Inflammation Research
Abstract:Hongliang Zhang, 1 Jie Gao, 1 Wenxiang Fang, 1 Yujie Tang, 1 Xuan Fang, 1 Tengchuan Jin, 2 Jinhui Tao 1 1 Department of Rheumatology and Immunology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, People's Republic of China; 2 Laboratory of Structural Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, People's Republic of China Correspondence: Jinhui Tao; Tengchuan Jin, Email ; Objective: To determine the role of nerve injury-induced protein 1 (NINJ1) introduced plasma membrane rupture (PMR) and damage-associated molecular patterns (DAMPs) release in the pathogenesis and progression of gout and to explore the potential of NINJ1 as a therapeutic target in gout. Methods: Both peripheral blood mononuclear cells (PBMCs) and serum sample from gout patients (n = 58) and healthy controls (n = 16) were collected and processed to NINJ1 expression, lactate dehydrogenase (LDH) detection, NINJ1 inhibition, and NINJ1 expression experiments, respectively. NINJ1 knockdown was carried out by lentivirus in a monosodium urate (MSU) induced rat model, and NINJ1 neutralizing antibody was applied in a MSU induced mouse model. Results: Our results found that NINJ1 was upregulated during a gout flare, and the resulting induction of PMR correlated with gout progression. NINJ1 knockdown significantly reduced the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and joint swelling in the rat model, and NINJ1 neutralizing antibody also significantly reduced gout flare in the mouse model and PBMCs. Moreover, NINJ1 expression is under NLRP3 inflammasome produced interleukin (IL)-1β control. Conclusion: These results support the notion of a pathogenic role of NINJ1 introduced PMR in gout and provide a detailed mechanism for gout pathogenesis involving inflammatory cell death and DAMPs release introduced by IL-1β. In addition, targeting NINJ1 might be a potential therapeutic approach for gout. Keywords: gout arthritis, NINJ1, NLRP3 inflammasome, plasma membrane rupture, therapeutic target Gout is an inflammatory disease resulting from MSU crystal deposition in joints and other tissues. Patients with gout always suffer from recurrent joints swelling and a great deal of pain. 1 According to the recurrence of a gout flare, gout is subdivided into acute phase and chronic phase, acute gout possesses less recurrence and always self-remission within 7–10 days, chronic gout possesses higher recurrence and lost self-remission. 2 Both genetic and environmental factors affect urate metabolism and can lead to hyperuricemia. This physiological change can result in MSU crystal formation, and activate the NLRP3 inflammasome inside of inflammatory cells synergistically with other stimuli. 3–7 Activated NLRP3 inflammasomes result in caspase-1 activation, which then cleave pro-IL-1β and Gasdermin-D (GSDMD), after which the cleaved GSDMD amino-terminal can insert into the plasma membrane and oligomerize to form a pore, allowing the release of small molecules, such as mature IL-1β to initiate inflammation. 8 IL-1β, in co-ordination with other cytokines such as tumor necrosis factor (TNF)-α and IL-6, promotes the recruitment of neutrophils at the inflamed joint, after which neutrophils were activated by MSU crystals further amplifying the inflammatory process. 9 Once GSDMD was cleaved, inflammatory cells either experience pyroptosis or survive and became super activated with inflammatory cytokines consistently secreted. 10 Pyroptosis occurs with PMR and the release of large molecules including abundant DAMPs, which further activate the NLRP3 inflammasome and other inflammatory pathways promoting inflammation. 11 In addition, the NLRP3 inflammasome can also trigger other types of cell death including necrosis, 12 MSU could also induce necrosis in a mixed lineage kinase domain-like protein (MLKL) dependent manner. 13,14 Putatively, these inflammatory cell death results in vast PMR and DAMP release, leading to the hyperinflammation responsible for extremely painful gout flare. PMR plays a central role in this inflammation amplification. NINJ1 was first identified as an adhesion molecule mainly expressed in neurons and Schwann cells and upregulated after nerve injury to induce neurite outgrowth. 15 Later studies found that it was also expressed in other cell types and involved in many diseases including cancer and autoimmune diseases. 16–21</ -Abstract Truncated-
immunology